Equities Analysts Set Expectations for RYTM FY2026 Earnings
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) – Investment analysts at HC Wainwright issued their FY2026 earnings per share estimates for Rhythm Pharmaceuticals in a research report issued to clients and investors on Monday, March 3rd. HC Wainwright analyst R. Selvaraju forecasts that the company will post earnings per share of ($1.49) for the year. […]
